Waypoint is delighted to have advised Cambridge Healthcare Research (CHR), a leading provider of specialist intelligence and research services for businesses in healthcare and life sciences, on its sale to GlobalData Healthcare, the healthcare division of GlobalData Plc.
A significant milestone for CHR
CHR provides strategic market understanding for decision makers in the healthcare and life science sectors. Combining market research, strategic competitive intelligence and pricing capabilities, CHR combines deep sector expertise, rigorous analysis and differentiated insight to enable its clients to make informed, timely decisions.
Established in 2013, Cambridge Healthcare Research quickly established itself as a leading firm in its sector and received the Queen’s Award for Enterprise in 2020. Now employing over 130 exceptional individuals, CHR is still driven by the founder’s entrepreneurial spirit and dedication to being the trusted partner of choice for decision makers in healthcare and life sciences.
Joining the GlobalData Group is a significant milestone for CHR. Global Data’s data, insight, and technology offerings will significantly enhance CHR’s capabilities while retaining the same specialist expertise and client‑centric approach.
Matteo Perucchini, Co-Founder of CHR, will lead the combined Competitive Intelligence division within GlobalData Healthcare.
Waypoint’s role
Waypoint were appointed by CHR to shape and execute the transaction with GlobalData. We worked closely with CHR’s leadership team throughout the process and look forward to seeing CHR continue to thrive as part of GlobalData Healthcare.
